ResearcherLMU KlinikumActive in the last 2 years

Anne Marie Senz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-9773-6278; OpenAlex author ID A5038897060. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 8

Papers, trials and grants by year

2026: 2 papers

Papers 2

STING Ablation in T Cells Is Required for the Efficacy of STING Agonists in CAR-T Cell Immunotherapy of Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2026.01.031 ↗
RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/jitc-2025-013282 ↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sebastian Kobold · 2 shared papers, 2026 · strength 0.46
- Paper RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. DOI 10.1136/jitc-2025-013282 ↗
- Paper STING Ablation in T Cells Is Required for the Efficacy of STING Agonists in CAR-T Cell Immunotherapy of Pancreatic Canc… DOI 10.1053/j.gastro.2026.01.031 ↗
Max M. Schnurr · 1 shared paper, 2026 · strength 0.26
- Paper RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. DOI 10.1136/jitc-2025-013282 ↗
Lars M. König · 1 shared paper, 2026 · strength 0.26
- Paper RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. DOI 10.1136/jitc-2025-013282 ↗
Peter Duewell · 1 shared paper, 2026 · strength 0.26
- Paper RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma. DOI 10.1136/jitc-2025-013282 ↗
Ignazio Piseddu · 1 shared paper, 2026 · strength 0.21
- Paper STING Ablation in T Cells Is Required for the Efficacy of STING Agonists in CAR-T Cell Immunotherapy of Pancreatic Canc… DOI 10.1053/j.gastro.2026.01.031 ↗
Ivonne Regel · 1 shared paper, 2026 · strength 0.21
- Paper STING Ablation in T Cells Is Required for the Efficacy of STING Agonists in CAR-T Cell Immunotherapy of Pancreatic Canc… DOI 10.1053/j.gastro.2026.01.031 ↗
Veit Hornung · 1 shared paper, 2026 · strength 0.21
- Paper STING Ablation in T Cells Is Required for the Efficacy of STING Agonists in CAR-T Cell Immunotherapy of Pancreatic Canc… DOI 10.1053/j.gastro.2026.01.031 ↗
Julia V. Mayerle · 1 shared paper, 2026 · strength 0.21
- Paper STING Ablation in T Cells Is Required for the Efficacy of STING Agonists in CAR-T Cell Immunotherapy of Pancreatic Canc… DOI 10.1053/j.gastro.2026.01.031 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.